Hepatology Medical Billing Guide 2026: Best Practices, Challenges, and Denial Fixes

Hepatology medical billing guide 2026 turns on three things most general billing teams underrate: choosing the right elastography code, staging liver disease with enough ICD-10-CM specificity, and securing prior authorization before a high-cost therapy starts. Get those right and the rest of the liver revenue cycle becomes routine. Miss them and denials pile up on your most frequent services.

This guide is written for hepatologists, GI practices with a liver clinic, and the practice managers who run their billing. It covers what changed for 2026, the codes that carry the most risk, the challenges unique to liver care, and a step-by-step method to reduce claim denials in hepatology.

What Makes Hepatology Medical Billing Different?

Hepatology billing differs from general internal medicine because a single liver patient can generate imaging, procedures, specialty drug authorizations, lab panels, and months of care coordination. Each piece follows its own coding logic.

Consider a typical patient with MASH and suspected F2 fibrosis. In one quarter, your clinic may bill a new patient visit, a FibroScan, a hepatic function panel, a prior authorization for resmetirom or semaglutide, follow-up visits, and monthly care management. That’s six claim types, at least three payer policies, and a diagnosis that must stay consistent across all of them.

Disease progression adds another layer. A patient moves from steatosis to fibrosis to compensated cirrhosis and sometimes to decompensation, transplant evaluation, or hepatocellular carcinoma. The diagnosis codes must track that progression visit by visit. Coding last year’s stage on this year’s claim is one of the quietest ways liver practices lose money.

What Changed in Hepatology Billing for 2026?

Several regulatory and code-set changes affect liver practices this year. Here is a quick reference.

CMS confirmed the dual conversion factors and the -2.5% efficiency adjustment in its CY 2026 final rule fact sheet. The FY 2027 code set is available from the CMS ICD-10 code files page.

Which CPT Codes Do Hepatology Practices Bill Most?

Most liver clinics draw from a compact set of CPT and HCPCS codes. The table below lists the ones that drive revenue and the billing detail that most often trips up each one.

Code descriptors are summarized. Confirm current descriptors, NCCI edits and local coverage policies before billing.

Which ICD-10-CM Codes Matter Most in Hepatology?

Liver diagnoses reward specificity. A vague code may be valid, yet still fail the payer’s medical necessity check for elastography, a specialty drug, or a lab panel.

The MASLD and MASH mapping follows an international expert consensus published in a peer-reviewed study on coding the new steatotic liver disease nomenclature, which found strong agreement that existing NAFLD and NASH codes should carry the new terms.

What Are the Biggest Hepatology Billing Challenges?

1. Choosing between 91200 and 76981 for liver elastography

FibroScan and similar exams can be billed two ways. 76981 fits when the exam includes ultrasound image guidance, image interpretation and documentation. 91200 fits when those elements aren’t performed or documented. The device alone doesn’t decide the code; the work you document does.

Practices get burned in two ways. Some bill 91200 on autopilot when the exam supports 76981. Others bill both codes for one exam because a vendor suggested it, and payers deny the second line as included in the first. We cover the device-level details on our hepatology billing page, including how modifiers 26 and TC split the professional and technical components in a hospital setting.

2. Staging fibrosis with enough specificity

Before October 2026, a patient with F2 fibrosis had no exact code. Coders chose K74.00 or stretched K74.01, and neither matched the clinical picture that payers wanted for MASH drug approvals. K74.0A fixes that, but only if your providers document the stage and the method (elastography value, biopsy result, or serum score). If the note says “fibrosis” with no stage, the coder can’t assign K74.0A.

3. Prior authorization for high-cost liver therapies

Direct-acting antivirals for hepatitis C, hepatitis B antivirals, and the newer MASH therapies all carry prior authorization requirements on most commercial plans. Policy language for MASH drugs commonly asks for confirmed MASH with F2 or F3 fibrosis and excludes patients with cirrhosis. Highmark’s medical policy, for example, treats resmetirom and semaglutide as investigational for MASH when cirrhosis is present. A request that lists only K75.81 without the fibrosis stage or supporting test results often stalls.

Authorization also has a clock. Many approvals run for a fixed period and need renewal with evidence of response. Missing the renewal date interrupts therapy and creates denials on the follow-up services tied to it.

4. Bundling and NCCI edits on liver procedures

Liver procedures bundle in ways that aren’t obvious. Paracentesis with imaging (49083) already includes the guidance, so adding 76942 is an error. A liver biopsy (47000) can carry separately reported ultrasound guidance. A same-day E/M visit with a procedure needs modifier 25 and documentation that shows a significant, separately identifiable service. Check pairs against the CMS Medicare NCCI edit tables before the claim leaves.

5. Care management revenue left on the table

Cirrhosis, chronic hepatitis B, and post-transplant care need monthly coordination: lab tracking, medication adjustments, diuretic titration, and calls with transplant centers. Much of that work is billable under chronic care management or principal care management, but only with consent, a care plan, and time logs. Many liver clinics do the work and never bill it. With the 2026 efficiency adjustment shaving procedure payments, these time-based codes matter more than they used to.

6. Payer coverage that varies by test and technology

Commercial plans don’t treat every noninvasive liver test the same way. Some cover transient elastography while labeling newer ultrasound-based techniques investigational, and a few require specific diagnoses before they’ll pay for repeat testing. Before you add a new device or test, pull the current policies for your top payers from the Medicare Coverage Database and each commercial plan’s medical policy library.

7. Transplant evaluation and multi-provider coordination

Transplant evaluation spreads services across hepatology, imaging, cardiology, labs, and the transplant center. Some services fall under the transplant center’s arrangements, while others bill normally from your practice. Without a clear handoff, practices either bill services the center already covers or miss services that belong to them. Confirm with each transplant program which pre-listing services it expects to bill.

How to Reduce Claim Denials in Hepatology

Denials keep climbing across healthcare. Experian Health’s 2025 State of Claims survey found that 41 percent of providers now face denial rates of 10 percent or higher. Liver practices can beat that number by fixing problems at the front end rather than appealing them later. This seven-step method works for a solo hepatologist or a multi-provider GI group.

1. Verify eligibility and benefits before every procedure visit. Re-check coverage for patients on Medicaid or marketplace plans each month, since their coverage changes often.
2. Start prior authorization at the order, not at the appointment. Attach the fibrosis stage, the test that established it, and prior treatment history. Log the approval number and expiration date in the scheduling system.
3. Use specialty documentation templates. Build note fields for fibrosis stage and method, elastography interpretation, ascites status, encephalopathy grade, and HCV treatment week. Coders can’t code what the template doesn’t capture.
4. Scrub claims with liver-specific rules. Flag 91200 and 76981 on the same claim, 76942 with 49083, missing K74.0- stage with K75.81 on drug-related visits, and retired codes such as 99441.
5. Apply modifiers with evidence. Use modifier 25 only when the note supports a separate E/M. Use 26 or TC by place of service. Use 59 or the X modifiers only when NCCI allows the bypass.
6. Work denials by root cause, not one at a time. Group denials by CARC code and fix the upstream step that caused them. The table below shows common patterns.
7. Review the numbers monthly. Track first-pass acceptance, denial rate by payer and CPT, and days in A/R. A sudden rise on one code usually means a policy change.

If your team needs help clearing a backlog, our denial management services trace each denial category to its source, so the same error stops repeating.

Hepatology Billing Best Practices Checklist

Use this checklist during your next billing review. Each item targets a recurring gap in liver practice claims.

• Load the FY 2027 ICD-10-CM codes, including K74.0A and K76.83, into your EHR and scrubber.
• Remove 99441 to 99443 from charge masters, order sets, and telehealth templates.
• Write a one-page elastography policy that states when your clinic bills 76981 versus 91200, and train providers on the documentation each needs.
• Require the fibrosis stage and staging method in every MASH and hepatitis note.
• Keep a payer grid for your top five plans covering elastography, liver biopsy, MASH drugs, DAAs and repeat lab limits.
• Enroll eligible cirrhosis and chronic hepatitis patients in CCM or PCM and log time in a dedicated field.
• Audit 10 to 20 charts per provider each quarter, focused on E/M levels, modifier 25 use and diagnosis specificity.
• Track authorization expiration dates and start renewals at least two weeks ahead.
• Confirm which transplant evaluation services the transplant center bills before you schedule them.

For the HCV portion of your practice, two related guides go deeper: Medicare’s hepatitis C screening rules and denial fixes, and which CPT code fits HCV screening in different settings.

What Does Strong Hepatology Revenue Cycle Management Look Like?

Hepatology revenue cycle management covers every step from scheduling to final payment, with extra checkpoints for authorizations and disease staging. A strong liver RCM workflow looks like this:

1. Scheduling and intake: capture insurance, referral, and prior records, including any outside elastography or biopsy results.
2. Eligibility and authorization: verify benefits and start authorizations for procedures and specialty drugs.
3. Documentation: providers complete specialty templates the same day.
4. Coding and charge entry: certified coders assign CPT, ICD-10-CM and modifiers, with care management time logged separately.
5. Claim scrubbing and submission: payer and NCCI edits run before release.
6. Payment posting: compare each payment with the contracted rate to catch underpayments.
7. Denials and A/R follow-up: appeal what’s recoverable and correct the upstream cause.
8. Reporting: monthly KPIs by provider, payer and code.

Practices that handle this in-house need staff who understand liver-specific rules. Others hand the whole cycle to a partner offering full revenue cycle management. Either way, measure the same numbers.

Targets are common practice-management benchmarks, not payer requirements. Set your own based on payer mix and specialty volume.

When aging claims creep past 90 days, you need a team that can work aging A/R before it crosses timely filing limits.

Should a Hepatology Practice Outsource Billing?

The answer depends on volume, staff depth and how much of your revenue comes from procedures and specialty drugs.

If you’re weighing a switch, look for a partner whose coders can explain the 76981 versus 91200 decision and the new K74.0A code without hesitation. Our AAPC-certified medical coding support is built around that kind of specialty detail.

Frequently Asked Questions

Keep Your Liver Clinic’s Revenue Moving

Hepatology billing rewards practices that treat it as a specialty. The 2026 changes raise the stakes: a new fibrosis code that payers will expect to see, procedure payments trimmed by the efficiency adjustment, and authorization rules that hinge on staging. Practices that update templates, scrub for liver-specific errors, and capture care management time will hold onto revenue that others lose.